Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Association of long non-coding RNA H19 and microRNA-21 expression with the biological features and prognosis of non-small cell lung cancer

Abstract

In recent years, long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) have been shown to play important roles in tumor biological function. The aim of this study was to investigate the diagnostic and prognostic value of lncRNA H19 and miR-21 expression in non-small-cell lung cancer (NSCLC). H19 and miR-21 expression was measured in tumor tissues and corresponding non-tumor lung tissues from 200 patients by quantitative reverse transcription polymerase chain reaction. Moreover, the in vitro and in vivo effects of H19 knock out in A549 cells were investigated. Expression of both H19 and miR-21 was significantly higher in lung tissues from patients with NSCLC than in normal lung tissues. Increased expression of H19 and miR-21 was positively correlated with advanced tumor-node-metastasis stage and tumor size. miR-21 expression was highest in stage I and II NSCLC, whereas H19 expression was highest in stage III and IV NSCLC. Knockout of H19 significantly inhibited NSCLC cell proliferation both in vitro and in vivo. The results show that H19 may mainly contributes to the progression of NSCLC, and its expression levels can reflect the invasive and metastatic status to some extent. miR-21 expression more likely plays an important role in early stage NSCLC. Moreover, H19 and miR-21 interact in the regulation of NSCLC, and with greater expression of both H19 and miR-21, overall survival decreased. The combination of H19 and miR-21 may have diagnostic value in NSCLC and represent a target for new NSCLC treatments.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Siegel R, Ma J, Zou Z, Jemal A . Cancer statistics, 2014. Cancer J Clin 2014; 64: 9–29.

    Article  Google Scholar 

  2. Ferlay J, Soerjomataram II, Dikshit R, Eser S, Mathers C, Rebelo Ml . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: 359–386.

    Article  Google Scholar 

  3. Puglisi M, Dolly S, Faria A, Myerson JS, Popat S, O’Brien ME . Treatment options for small cell lung cancer—do we have more choice? Br J Cancer 2010; 102: 629–638.

    Article  CAS  Google Scholar 

  4. Dinger ME, Amaral PP, Mercer TR, Pang KC, Bruce SJ, Gardiner BB . Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Res. 2008; 18: 1433–1445.

    Article  CAS  Google Scholar 

  5. Ginger MR, Shore AN, Contreras A, Rijnkels M, Miller J, Gonzalez-Rimbau MF . Anoncoding RNAis a potential marker of cell fate during mammary gland development. Proc Natl Acad Sci USA 2006; 103: 5781–5786.

    Article  CAS  Google Scholar 

  6. Gao L, Mai A, Li X, Lai Y, Zheng J, Yang Q . LncRNADQ786227- mediated cell malignant transformation induced by benzo(a)pyrene. Toxicol Lett 2013; 223: 205–210.

    Article  CAS  Google Scholar 

  7. Batista PJ, Chang HY . Long noncoding RNAs: cellular address codes in development and disease. Cell 2013; 152: 1298–1307.

    Article  CAS  Google Scholar 

  8. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A et al. Landscape of transcription in human cells. Nature 2012; 489: 101–108.

    Article  CAS  Google Scholar 

  9. Enfield KS, Pikor LA, Martinez VD, Lam WL . Mechanistic roles of noncoding RNAs in lung cancer biology and their clinical implications. Genet Res Int 2012; 2012: 737416.

    PubMed  PubMed Central  Google Scholar 

  10. Yang Q, Zhang S, Liu H, Wu Jl . Oncogenic role of long noncodingRNA AF118081 inanti-benzoapyrene-trans-7,8-dihydrodiol-9,10-epoxide-transformed 16HBE cells. Toxicol Lett 2014; 229: 430–439.

    Article  CAS  Google Scholar 

  11. Mercer TR, Dinger ME, Mattick JS . Long non-coding RNAs: insights into functions. Nat Rev Genet 2009; 10: 155–159.

    Article  CAS  Google Scholar 

  12. Ng SY, Lin L, Soh BS, Stanton LW . Long noncoding RNAs in development and disease of the central nervous system. Trends Genet 2013; 29: 461–468.

    Article  CAS  Google Scholar 

  13. Zhang J, Zhang P, Wang L, Piao HL, Ma L . Long non-coding RNA HOTAIR in carcinogenesis and metastasis. Acta Biochim Biophys Sin 2014; 46: 1–5.

    Article  Google Scholar 

  14. Qiu MT, Hu JW, Yin R, Xu L . Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biol: J Int Soc Oncodev Biol Med 2013; 34: 613–620.

    Article  CAS  Google Scholar 

  15. Okazaki Y, Furuno M, Kasukawa T, Adachi J, Bono H, Kondo S . Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature 2002; 420: 563–573.

    Article  Google Scholar 

  16. Ji P, Diederichs S, WangW, Boing S, Metzger R, Schneider PM . MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003; 22: 8031–8041.

    Article  Google Scholar 

  17. Shi X, Sun M, Liu H, Yao Y, Song Y . Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett 2013; 339: 159–166.

    Article  CAS  Google Scholar 

  18. Chan JA, Krichevsky AM, Kosik KS . MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65: 6029–6033.

    Article  CAS  Google Scholar 

  19. Yaodong Z, Bo S . The significance and correlation of microRNA-21 expression with biological features and prognosis of neuroblastoma (NB). Cancer Control 2016; 23: 78–84.

    Article  Google Scholar 

  20. Si ML, Zhu S, Wu H, LU Z, Wu F, Mo YY et al. miR-21-mediated tumor growth. Oncogene 2007; 26: 2799–2803.

    Article  CAS  Google Scholar 

  21. Nagano T, Fraser P . No-nonsense functions for long noncoding RNAs. Cell 2011; 145: 178–181.

    Article  CAS  Google Scholar 

  22. Park JY, Lee JE, Park JB, Yoo H, Lee SH, Kim JH . Roles of long noncoding RNAs on tumorigenesis and glioma development. Brain Tumor Res Treatment 2014; 2: 1–6.

    Article  Google Scholar 

  23. Ponjavic J, Ponting CP, Lunter G . Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs. Genome Res 2007; 17: 556–565.

    Article  CAS  Google Scholar 

  24. Zhou Y, Sheng B . Association of microRNA 21 With Biological Features and Prognosis of Neuroblastoma. Cancer Control 2016; 23: 78–84.

    Article  Google Scholar 

  25. Lu X, Fang Y, Wang Z, Xie J, Zhan Q, Deng X . Downregulation of gas5 increases pancreatic cancer cell proliferation by regulating CDK6. Cell Tissue Res 2013; 354: 891–896.

    Article  CAS  Google Scholar 

  26. Mourtada-Maarabouni M, Williams GT . Growth arrest on inhibition of nonsense-mediated decay is mediated by noncoding RNA GAS5. BioMed Res Int 2013; 13: 358D15.

    Google Scholar 

  27. Weber DG, Johnen G, Casjens S, Bryk O, Pesch B, Jockel KH . Evaluation of long noncoding RNA MALAT1 as a candidate bloodbased biomarker for the diagnosis of non-small cell lung cancer. BMC Res Notes 2013; 6: 518.

    Article  Google Scholar 

  28. Tay Y, Rinn J, Pandolfi PP . The multilayered complexity of ceRNA crosstalk and competition. Nature 2014; 505: 344–352.

    Article  CAS  Google Scholar 

  29. Anko ML, Muller-McNicoll M, Brandl H . The RNA binding landscapes of two SR proteins reveal unique functions and binding to diverse RNA classes. Genome Biol 2012; 13: R17–R32.

    Article  Google Scholar 

  30. Liu Z, Sun M, Lu K, Liu J, Zhang M, Wu W . The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregulation of p21(WAF1/CIP1) expression. PLoS ONE 2013; 8: e77293.

    Article  CAS  Google Scholar 

  31. Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 2010; 39: 133–144.

    Article  CAS  Google Scholar 

  32. Ling H, Fabbri M, Calin GA . MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov 2013; 12: 847–865.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Reginald C. Tsang, MD and Hao WU, MD, for help in editing this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Y Zhou or Q Xia.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, Y., Sheng, B., Xia, Q. et al. Association of long non-coding RNA H19 and microRNA-21 expression with the biological features and prognosis of non-small cell lung cancer. Cancer Gene Ther 24, 317–324 (2017). https://doi.org/10.1038/cgt.2017.20

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2017.20

This article is cited by

Search

Quick links